EARNINGS ARE EXPLODING AND LOW SHARE COUNT MAKES THIS VERY ATTRACTIVE.

THE OTHER POSSIBILITY IS ASTRA Z WHO IS A PARTNER THAT MAY LOOK TO FEND OFF PATENT EXPIRES WITH A STRONG US GENERIC.

PRICE HEAD OF ADRX BEFORE IT WAS SOLD JOINED PRX BOARD IN JULY AND NOW IS PART OF AN INVESTMENT CO.

PLANS ARE IN PLACE FOR PRX TO BE SOLD. LOOK FOR THE MID $30'S